Dunham P B, Jessen F, Hoffmann E K
Department of Biology, Syracuse University, NY 13244.
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6828-32. doi: 10.1073/pnas.87.17.6828.
Two proteins were purified earlier from solubilized membranes of Ehrlich ascites cells by using a bumetanide-Sepharose affinity column. These proteins were proposed to be constituents of the Na-K-C1 cotransporter. However, the specificity of binding of bumetanide to the cotransporter was insufficient evidence for this proposal. We now have direct evidence that the purified protein contains components of the cotransporter. Antiserum raised against the bumetanide-binding proteins strongly inhibits Na-K-C1 cotransport measured by two independent methods. Cotransport was induced by hypertonic challenge and was measured as the bumetanide-sensitive portion of unidirectional C1 influx and as regulatory cell volume increase. In both assays, cotransport was strongly inhibited by the antiserum. Fab fragments of the antibodies inhibited cotransport to a similar extent.
早前通过使用布美他尼-琼脂糖亲和柱从艾氏腹水癌细胞的溶解膜中纯化出了两种蛋白质。这些蛋白质被认为是钠-钾-氯共转运体的组成成分。然而,布美他尼与共转运体结合的特异性不足以支持这一说法。我们现在有直接证据表明,纯化的蛋白质包含共转运体的成分。针对布美他尼结合蛋白产生的抗血清通过两种独立方法强烈抑制钠-钾-氯共转运。共转运由高渗刺激诱导,并作为单向氯流入的布美他尼敏感部分以及调节性细胞体积增加来测量。在这两种测定中,共转运均被抗血清强烈抑制。抗体的Fab片段对共转运的抑制程度相似。